Aileron Therapeutics Inc (ALRN)

HEALTH CARE: PHARMACEUTICALS
SIC: SERVICES-SOCIAL SERVICES

375 N BROADWAY JERICHO, NY 11753

Aileron Therapeutics Inc. is a clinical-stage biopharmaceutical company that is focused on enabling patients to fight cancer without the fear or burden of chemotherapy-induced side effects. The company believes selective chemoprotection has the potential to fundamentally transform chemotherapy like anesthesia transformed surgery.

Data as of 2021-07-19 09:41:05 -0400
Market Cap94.844 Million Shares Outstanding90.328 Million Avg 30-day Volume450.275 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.14 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.38734 52-week High/Low2.47 / 0.84 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -16.1551
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from ALRN instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 52 30 73.33% 18 (1.06%) 7 (0.41%) 157.14%
13F shares: 33.502 Million 10.342 Million 223.94% 27.886 Million 8.955 Million 211.39%
% Ownership 37.1379 23.6099 57.3% 30.9123 20.4444 51.2%
New Positions: 25 12 108.33% 11 2 450.0%
Increased Positions 14 6 133.33% 5 3 66.67%
Closed Positions 2 10 -80.0% 3
Reduced Positions 3 3 0.0% 1 1 0.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALRN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALRN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANNIS ALLEN SVP, RESEARCH

  • Officer
474,000 2021-06-15 1

AMBROS REINHARD J.

  • Director
96,000 2021-06-15 1

MORRISON JODIE POPE

  • Director
96,000 2021-06-15 1

AIVADO MANUEL SEE REMARKS

  • Officer
  • Director
2,440,000 2021-06-15 1

BAILEY JEFFREY ALLEN

  • Director
96,000 2021-06-15 1

VUKOVIC VOJO CHIEF MEDICAL OFFICER

  • Officer
400,000 2021-06-15 1

SIGAL NOLAN HOWARD

  • Director
96,000 2021-06-15 1

WANSTALL RICK SEE REMARKS

  • Officer
600,000 2021-06-15 1

MCKEE WILLIAM

  • Director
96,000 2021-06-15 1

VON RICKENBACH JOSEF H

  • Director
96,000 2021-06-15 1

SATTER MUNEER A SEE REMARKS

  • Officer
  • Director
16,609,449 2021-01-08 1

GREGORY KATHRYN SVP, CHIEF BUSINESS OFFICER

  • Officer
0 2020-01-31 0

MCARTHUR JOHN H

  • Director
0 2019-06-19 0

DOUGHERTY DONALD SVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2019-04-15 0

NOVARTIS BIOVENTURES LTD

NOVARTIS AG

  • 10% Owner
No longer subject to file 2019-03-29 0

LONGENECKER JOHN P PHD PRESIDENT AND CEO

  • Officer
10,000 2018-08-10 0

APPLE TREE PARTNERS II - ANNEX, L.P.

  • 10% Owner
No longer subject to file 2018-07-06 0

APPLE TREE PARTNERS II LP

  • 10% Owner
No longer subject to file 2018-07-06 0

WINDER CALEB MAXFIELD

  • Director
0 2018-06-21 0

SHANAFELT ARMEN

  • Director
0 2018-06-21 0

KAPNICK SCOTT

  • Director
0 2017-07-25 0

NELSON KIRA SEE REMARKS

  • Officer
0 2017-07-25 0

GALLAGHER BRIAN M. JR.

  • Director
0 2017-07-25 0

YANCHIK JOSEPH A., III SEE REMARKS

  • Officer
  • Director
0 2017-07-25 0

KCK LTD.

  • 10% Owner
No longer subject to file 2017-07-05 0

ROCHE HOLDING LTD

ROCHE FINANCE LTD

  • 10% Owner
No longer subject to file 2017-07-05 0

AJU IB INVESTMENT CO., LTD.

  • 10% Owner
No longer subject to file 2017-07-05 0

CVF, LLC

  • 10% Owner
No longer subject to file 2017-07-05 0

LV MANAGEMENT GROUP, LLC

LILLY VENTURES FUND I LLC

TORRES S. EDWARD

HALL STEVEN EDWARD

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2017-07-05 0

PLATT JON B.

  • 10% Owner
No longer subject to file 2017-07-05 0

EXCEL MEDICAL FUND LP

GULLANS STEVEN R. PH.D.

BLUME FREDERICK R.

ENRIQUEZ JUAN

EXCEL MEDICAL VENTURES, LLC

  • 10% Owner
No longer subject to file 2017-07-05 0

SIGMA EMERGING MARKETS LTD.

  • 10% Owner
No longer subject to file 2017-07-05 0

GLAXOSMITHKLINE PLC

  • 10% Owner
0 2017-06-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VON RICKENBACH JOSEF H - Director

2021-06-17 19:51:43 -0400 2021-06-15 A 96,000 a 96,000 direct

BAILEY JEFFREY ALLEN - Director

2021-06-17 19:58:29 -0400 2021-06-15 A 96,000 a 96,000 direct

MORRISON JODIE POPE - Director

2021-06-17 19:55:18 -0400 2021-06-15 A 96,000 a 96,000 direct

ANNIS ALLEN - Officer SVP, RESEARCH

2021-06-17 19:49:29 -0400 2021-06-15 A 474,000 a 474,000 direct

WANSTALL RICK - Officer SEE REMARKS

2021-06-17 19:54:37 -0400 2021-06-15 A 600,000 a 600,000 direct

VUKOVIC VOJO - Officer CHIEF MEDICAL OFFICER

2021-06-17 19:51:38 -0400 2021-06-15 A 400,000 a 400,000 direct

SIGAL NOLAN HOWARD - Director

2021-06-17 19:50:04 -0400 2021-06-15 A 96,000 a 96,000 direct

AIVADO MANUEL - Director - Officer SEE REMARKS

2021-06-17 19:56:40 -0400 2021-06-15 A 2,440,000 a 2,440,000 direct

AMBROS REINHARD J. - Director

2021-06-17 19:55:02 -0400 2021-06-15 A 96,000 a 96,000 direct

MCKEE WILLIAM - Director

2021-06-17 19:51:56 -0400 2021-06-15 A 96,000 a 96,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AILERON THERAPEUTICS INC ALRN 2021-07-23 22:15:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 21:45:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 21:15:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 20:45:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 20:15:05 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 19:45:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 19:15:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 18:45:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 18:15:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 17:45:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 17:15:02 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 16:45:02 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 16:15:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 15:45:02 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 15:15:03 UTC -2.5996 2.6796 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 14:45:03 UTC -2.4472 2.5272 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 14:15:03 UTC -2.4472 2.5272 1000000
AILERON THERAPEUTICS INC ALRN 2021-07-23 13:45:03 UTC -2.4472 2.5272 1000000
AILERON THERAPEUTICS INC ALRN 2021-07-23 13:15:03 UTC -2.4472 2.5272 1100000
AILERON THERAPEUTICS INC ALRN 2021-07-23 12:45:03 UTC -2.4472 2.5272 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments